ChatGPT Potentially Beneficial for Treating Depression
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 18, 2023 -- ChatGPT provides recommendations that align with accepted guidelines for management of mild and severe depression, according to a study published online Oct. 4 in Family Medicine and Community Health.
Inbar Levkovich, Ph.D., from Oranim Academic College in Tivon, Israel, and Zohar Elyoseph, Ph.D., from Imperial College London, input vignettes to the ChatGPT interface, focusing mainly on hypothetical patients with symptoms of depression during initial consultations. Eight distinct versions were designed in which patient attributes and depression severities were varied. Each variant was introduced into ChatGPT-3.5 and ChatGPT-4; to ensure consistency and reliability of ChatGPT responses, each vignette was repeated 10 times.
The researchers found that ChatGPT-3.5 and ChatGPT-4 recommended psychotherapy in 95.0 and 97.5 percent of cases, respectively, for mild depression, while primary care physicians recommended psychotherapy in 4.3 percent of cases. For severe cases, primary care physicians mostly recommended "referral for psychotherapy and prescription of pharmacological treatment"; ChatGPT favored this approach more frequently. ChatGPT-3.5 and ChatGPT-4 showed a preference for exclusive use of antidepressants (74 and 68 percent, respectively) in pharmacological recommendations, while primary care physicians generally recommended antidepressants and anxiolytics/hypnotics (67.4 percent). ChatGPT showed no gender or socioeconomic biases in its recommendations, unlike primary care physicians.
"The study suggests that ChatGPT, with its commitment to treatment protocols and absence of biases, has the potential to enhance decision-making in primary health care," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Risk of Suicide, Homicide Both Higher at Night
FRIDAY, June 7, 2024 -- The risk of suicide and homicide is higher at night than might be expected based on the number of people awake at that time, according to a study published...
Social Media Use Tied to Depression, but Not Sole Cause in Young Adults
FRIDAY, June 7, 2024 -- Social media use and depression are associated, but social media use is not prospectively related to the course of depressive symptoms, according to a...
Many Patients Have Discontinuation Symptoms After Stopping Antidepressants
THURSDAY, June 6, 2024 -- A considerable proportion of patients have discontinuation symptoms (e.g., dizziness, headache, nausea, insomnia, and irritability) after...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.